Q4392 Grafix Duo HCPCS Reimbursement Benchmarks

HCPCS Level II code Q4392 designates Grafix Duo, a biologic wound matrix billed per square centimeter as an add-on item to a primary procedure. The code covers adjunctive grafting or coverage used in wound management and is relevant to providers, facilities, and payers involved in outpatient wound care. Nationally, utilization of biologic wound matrices has implications for cost, clinical outcomes in complex wounds, and payer coverage policies.

Key payers in the scope of this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication provides a concise overview of coverage practices, pricing benchmarks, coding and billing considerations for add-on biologic products, and clinical contexts in which Q4392 is typically used. Readers will learn how Q4392 is reported in conjunction with primary wound procedures, typical sites of service where the product is applied, and common operational considerations for billing and documentation. The report also summarizes available national-level policy and reimbursement themes relevant to biologic wound matrices.

Data not available in the input for specific contractual rates, associated ICD-10 diagnoses, taxonomies, and related codes.

Billing Code Overview

HCPCS Level II code Q4392 represents Grafix Duo, billed per square centimeter as an add-on item to be reported in addition to a primary procedure. The product is a biologic wound matrix indicated for use in wound care applications where adjunctive coverage or grafting is provided.

Service type: Wound care biologic grafting/adjunctive wound matrix

Typical site of service: Outpatient wound care clinic, hospital outpatient department, ambulatory surgery center, or other outpatient settings where the primary procedure is performed

Clinical Context

A 68-year-old patient with a chronic, non-healing full-thickness lower-extremity wound presents to a wound care clinic. Prior conservative measures (debridement, offloading, compression, topical antimicrobials) failed to demonstrate progressive granulation over 4–6 weeks. The clinician determines that an advanced biologic allograft is appropriate. In the outpatient procedure room, after appropriate wound bed preparation and local anesthesia as needed, the clinician applies a placental-derived bilayer cryopreserved matrix product (Grafix duo) trimmed to size and secured in place. The product is billed per square centimeter using HCPCS Level II code Q4392 as an add-on item in addition to the primary procedure (for example, wound debridement or skin grafting). Typical workflow steps include wound assessment and measurement, documentation of prior failed therapies, charged primary procedure (debridement/closure), application of the Grafix duo graft by an appropriate specialist, and post-application dressing and follow-up plan with serial wound measurements.

Coding Specifications

Modifier	Description	When to Use
`00`	No modifier - standard billing	Use when no special billing modifier applies and the charge represents the standard supply billing.

Taxonomy Code	Specialty	Notes
`207RH0000X`	Surgery — Reconstructive Plastic Surgery	Plastic surgeons commonly apply advanced wound matrices and perform wound closure procedures.
`208000000X`	Surgery — General Surgery	General surgeons manage complex soft-tissue wounds and apply biologic grafts in outpatient or operative settings.
`174400000X`	Podiatry	Podiatrists commonly treat chronic lower-extremity wounds and apply advanced wound products.
`163W00000X`	Dermatology	Dermatologists specializing in procedural wound care may use biologic grafts for chronic skin wounds.
`365N00000X`	Nursing — Wound Care Nurse Specialist	Advanced practice wound care nurses perform applications and follow-up in multidisciplinary clinics.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`L97.422`	Non-pressure chronic ulcer of left calf with necrosis of muscle	Chronic lower-extremity ulcers are common indications for advanced biologic grafts when standard care fails.
`L97.521`	Non-pressure chronic ulcer of right ankle with necrosis of bone	Deep or non-healing ulcers with exposed structures may require advanced grafting and adjunctive therapies.
`E11.621`	Type 2 diabetes mellitus with foot ulcer	Diabetic foot ulcers frequently require advanced wound care products including placental-derived matrices.
`I83.019`	Varicose veins of right lower extremity with ulceration	Venous stasis ulcers are an indication for advanced wound products when conservative measures are insufficient.
`L89.153`	Pressure ulcer of left heel, stage 3	Pressure injuries that fail to progress may be treated with biologic grafts to promote granulation and closure.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`11042`	Debridement, subcutaneous tissue, first 20 sq cm or less	Often billed for sharp debridement of necrotic tissue immediately prior to application of an advanced biologic graft.
`97602`	Removal of devitalized tissue from wound(s), selective debridement, without anesthesia (e.g., high-pressure water jet)	Used for non-surgical debridement or wound care performed before graft placement.
`15271`	Application of skin substitute graft to trunk, arms, legs; first 100 sq cm or less, or 15275 for larger	Billed when a clinician applies a skin substitute graft as the primary procedure; `Q4392` is billed as an add-on per sq cm in addition to primary grafting when appropriate.
`12032`	Repair, intermediate, wounds of scalp, arms, and/or legs; 2.6 cm to 7.5 cm	Used when primary wound closure is performed in conjunction with biologic graft application.
`11043`	Debridement, muscle and/or fascia, first 20 sq cm or less	Billed for deeper surgical debridement required prior to application of a biologic graft.

OpenPayer

Summary & Overview

HCPCS Q4392: Grafix Duo Wound Matrix, Per Square Centimeter